We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.4B
AUM Growth
+$1.5B
Cap. Flow
+$1.66B
Cap. Flow %
7.75%
Top 10 Hldgs %
50.4%
Holding
201
New
31
Increased
27
Reduced
32
Closed
37

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.41B
2
CHTR icon
Charter Communications
CHTR
+$462M
3
CBRE icon
CBRE Group
CBRE
+$375M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$314M
5
VMW
VMware, Inc
VMW
+$285M

Top Sells

Rank Stock Value
1
EFX icon
Equifax
EFX
+$249M
2
IQV icon
IQVIA
IQV
+$239M
3
BIIB icon
Biogen
BIIB
+$172M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$130M
5
TMO icon
Thermo Fisher Scientific
TMO
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 31.13%
2 Technology 23.99%
3 Financials 9.09%
4 Communication Services 6.05%
5 Industrials 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRXB.WS
151
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$5.25K ﹤0.01%
250,000
– –
EQRXW
152
DELISTED
EQRx, Inc. Warrant
EQRXW
$4.82K ﹤0.01%
120,085
-1,140
-0.9% -$117
SLAMW
153
DELISTED
Slam Corp. warrant
SLAMW
$2.21K ﹤0.01%
17,627
– –
GETR.WS
154
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$1.56K ﹤0.01%
80,000
– –
ALVO icon
155
Alvotech
ALVO
$1.29B
– –
-437,110
Closed -$3.38M
ARGX icon
156
argenx
ARGX
$54.1B
– –
-161,000
Closed -$62.7M
ARWR icon
157
Arrowhead Research
ARWR
$12.4B
– –
-5,800
Closed -$207K
BIIB icon
158
Biogen
BIIB
$30.7B
– –
-604,098
Closed -$172M
BRKR icon
159
Bruker
BRKR
$8.14B
– –
-150,476
Closed -$11.1M
EFX icon
160
Equifax
EFX
$21.4B
– –
-1,058,697
Closed -$249M
EXAS
161
DELISTED
Exact Sciences
EXAS
– –
-602,000
Closed -$56.5M
ICE icon
162
Intercontinental Exchange
ICE
$84.4B
– –
-12,786
Closed -$1.45M
NTLA icon
163
Intellia Therapeutics
NTLA
$1.67B
– –
-116,000
Closed -$4.73M
PRVA icon
164
Privia Health
PRVA
$2.87B
– –
-74,000
Closed -$1.93M
TSEM icon
165
Tower Semiconductor
TSEM
$28.5B
– –
-1,160,000
Closed -$43.5M
UTHR icon
166
United Therapeutics
UTHR
$23.1B
– –
-193,267
Closed -$42.7M
TECX
167
Tectonic Therapeutic
TECX
$606M
– –
-74,975
Closed -$855K
CITE
168
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
– –
-350,000
Closed -$3.73M
KCGI
169
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
– –
-775,200
Closed -$8.19M
AEL
170
DELISTED
American Equity Investment Life Holding Company
AEL
– –
-383,000
Closed -$20M
BTTX
171
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
– –
-330,619
Closed -$357K
AMAM
172
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-2,269,000
Closed -$37.3M
FSRX
173
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
– –
-400,000
Closed -$4.09M
SYNH
174
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-3,075,000
Closed -$130M
RETA
175
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-451,700
Closed -$46.1M
4 5 6
7
8

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Farallon Capital Management held 201 positions worth $21.4B, up 7.5% from $19.9B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Farallon Capital Management deployed $1.66B of net new capital in Q3 2023, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Charter Communications: 1,111,341 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was IQVIA, an estimated $239M trimmed.

  • Farallon Capital Management's largest Q3 2023 buy was Charter Communications: 1,111,341 shares worth $489M.
  • Farallon Capital Management added most to Activision Blizzard in Q3 2023, an estimated $1.41B increase.
  • Farallon Capital Management's biggest Q3 2023 reduction was IQVIA, cutting an estimated $239M.
  • Farallon Capital Management fully exited Equifax in Q3 2023, selling an estimated $249M.
  • Farallon Capital Management's ten largest holdings make up 50% of its $21.4B portfolio in Q3 2023.
  • Farallon Capital Management opened 31 new positions and closed 37 in Q3 2023.
  • Farallon Capital Management's portfolio value rose 7.5% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.